Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy?
SPBx combined with TPBx maximized csPCa diagnosis; the use of reduced biopsy scheme limited to ipsilateral side of mpMRI lesion plus TPBx missed 11.6% csPCa. Only in the presence of PI-RADS score 5 SPBx and TPBx diagnosed both 100% of csPCa.
Authors
- Pietro Pepe (ORCID: https://orcid.org/0000-0002-8375-4419)
- Ludovica Pepe
- Mara Curduman
- Vincenzo Fiorentino (ORCID: https://orcid.org/0000-0002-1132-1761)
- Filippo Fraggetta (ORCID: https://orcid.org/0000-0002-0040-9987)
Institutions
- University of Messina (IT)
- University of Catania (IT)
- Istituto Ortopedico Gaetano Pini (IT)
- Ospedale Cannizzaro (IT)
- Abu Dhabi National Oil (United Arab Emirates) (AE)
Publication Details
- Journal
- Archivio Italiano di Urologia e Andrologia
- Published
- 2024-11-11
- DOI
- https://doi.org/10.4081/aiua.2024.12992
- Citations
- 7
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.93